A 0 1 0 1 O
total 2 7 2 7 O
of 8 10 8 10 O
39 11 13 11 13 O
patients 14 22 14 22 O
with 23 27 23 27 O
PDD 28 31 28 31 B-chronic_disease
as 32 34 32 34 O
defined 35 42 35 42 O
by 43 45 43 45 O
an 46 48 46 48 O
ejection 49 57 49 57 B-clinical_variable
fraction 58 66 58 66 I-clinical_variable
of 67 69 67 69 O
greater 70 77 70 77 O
than 78 82 78 82 O
50 83 85 83 85 B-lower_bound
% 85 86 85 86 I-lower_bound

Alfuzosin 0 9 87 96 B-treatment

Current 0 7 97 104 O
or 8 10 105 107 O
anticipated 11 22 108 119 O
future 23 29 120 126 O
need 30 34 127 131 O
for 35 38 132 135 O
nitrate 39 46 136 143 B-treatment
therapy 47 54 144 151 I-treatment

Diastolic 0 9 152 161 B-clinical_variable
blood 10 15 162 167 I-clinical_variable
pressure 16 24 168 176 I-clinical_variable
< 25 26 177 178 O
40 27 29 179 181 B-upper_bound
mmHg 30 34 182 186 I-upper_bound
or 35 37 187 189 O
> 38 39 190 191 O
100 40 43 192 195 B-lower_bound
mmHg 44 48 196 200 I-lower_bound

Doxazosin 0 9 201 210 B-treatment

Have 0 4 211 215 O
experienced 5 16 216 227 O
a 17 18 228 229 O
myocardial 19 29 230 240 B-chronic_disease
infarction 30 40 241 251 I-chronic_disease
or 41 43 252 254 O
unstable 44 52 255 263 B-chronic_disease
angina 53 59 264 270 I-chronic_disease

Hemoglobin 0 10 271 281 B-clinical_variable
< 11 12 282 283 O
9 12 13 283 284 B-upper_bound
g 14 15 285 286 I-upper_bound
/ 15 16 286 287 I-upper_bound
dL 16 18 287 289 I-upper_bound

Infiltrative 0 12 290 302 O
or 13 15 303 305 O
inflammatory 16 28 306 318 O
myocardial 29 39 319 329 B-chronic_disease
disease 40 47 330 337 I-chronic_disease
( 48 49 338 339 O
amyloid 49 56 339 346 O
, 56 57 346 347 O
sarcoid 58 65 348 355 O
) 65 66 355 356 O

Less 0 4 357 361 O
than 5 9 362 366 O
21 10 12 367 369 B-lower_bound
years 13 18 370 375 I-lower_bound
of 19 21 376 378 O
age 22 25 379 382 B-age

Non 0 3 383 386 O
- 3 4 386 387 O
cardiac 4 11 387 394 O
condition 12 21 395 404 O
limiting 22 30 405 413 O
life 31 35 414 418 B-clinical_variable
expectancy 36 46 419 429 I-clinical_variable
to 47 49 430 432 O
less 50 54 433 437 O
than 55 59 438 442 O
one 60 63 443 446 B-upper_bound
year 64 68 447 451 I-upper_bound
, 68 69 451 452 O
per 70 73 453 456 O
physician 74 83 457 466 O
judgment 84 92 467 475 O

Obstructive 0 11 476 487 B-chronic_disease
Hypertrophic 12 24 488 500 I-chronic_disease
cardiomyopathy 25 39 501 515 I-chronic_disease

Other 0 5 516 521 O
acute 6 11 522 527 O
or 12 14 528 530 O
chronic 15 22 531 538 O
medical 23 30 539 546 B-chronic_disease
conditions 31 41 547 557 I-chronic_disease
or 42 44 558 560 O
laboratory 45 55 561 571 O
abnormality 56 67 572 583 O
which 68 73 584 589 O
may 74 77 590 593 O
increase 78 86 594 602 O
the 87 90 603 606 O
risks 91 96 607 612 O
associated 97 107 613 623 O
with 108 112 624 628 O
study 113 118 629 634 O
participation 119 132 635 648 O
or 133 135 649 651 O
may 136 139 652 655 O
interfere 140 149 656 665 O
with 150 154 666 670 O
interpretation 155 169 671 685 O
of 170 172 686 688 O
the 173 176 689 692 O
data 177 181 693 697 O

Patients 0 8 698 706 O
on 9 11 707 709 O
PDEV 12 16 710 714 B-treatment
inhibition 17 27 715 725 I-treatment
for 28 31 726 729 O
erectile 32 40 730 738 B-chronic_disease
dysfunction 41 52 739 750 I-chronic_disease
who 53 56 751 754 O
are 57 60 755 758 O
not 61 64 759 762 O
willing 65 72 763 770 O
to 73 75 771 773 O
stop 76 80 774 778 O
the 81 84 779 782 O
medication 85 95 783 793 B-treatment
for 96 99 794 797 O
the 100 103 798 801 O
duration 104 112 802 810 O
of 113 115 811 813 O
the 116 119 814 817 O
study 120 125 818 823 O

Patients 0 8 824 832 O
on 9 11 833 835 O
PDEV 12 16 836 840 B-treatment
inhibition 17 27 841 851 I-treatment
for 28 31 852 855 O
pulmonary 32 41 856 865 B-chronic_disease
hypertension 42 54 866 878 I-chronic_disease

Patients 0 8 879 887 O
taking 9 15 888 894 O
alpha 16 21 895 900 B-treatment
antagonists 22 33 901 912 I-treatment
or 34 36 913 915 O
cytochrome 37 47 916 926 B-treatment
P450 48 52 927 931 I-treatment
3A4 53 56 932 935 I-treatment
inhibitors 57 67 936 946 I-treatment
( 68 69 947 948 O
ketoconazole 69 81 948 960 B-treatment
, 81 82 960 961 O
itraconazole 83 95 962 974 B-treatment
, 95 96 974 975 O
erythromycin 97 109 976 988 B-treatment
, 109 110 988 989 O
saquinavir 111 121 990 1000 B-treatment
, 121 122 1000 1001 O
cimetidine 123 133 1002 1012 B-treatment
or 134 136 1013 1015 O
serum 137 142 1016 1021 B-treatment
proteases 143 152 1022 1031 I-treatment
inhibitors 153 163 1032 1042 I-treatment
for 164 167 1043 1046 O
HIV 168 171 1047 1050 B-chronic_disease
) 171 172 1050 1051 O
who 173 176 1052 1055 O
can 177 180 1056 1059 O
not 180 183 1059 1062 O
be 184 186 1063 1065 O
taken 187 192 1066 1071 O
off 193 196 1072 1075 O
these 197 202 1076 1081 O
medications 203 214 1082 1093 B-treatment
for 215 218 1094 1097 O
the 219 222 1098 1101 O
duration 223 231 1102 1110 O
of 232 234 1111 1113 O
the 235 238 1114 1117 O
study 239 244 1118 1123 O

Patients 0 8 1124 1132 O
taking 9 15 1133 1139 O
the 16 19 1140 1143 O
following 20 29 1144 1153 O
selective 30 39 1154 1163 O
alpha 40 45 1164 1169 B-treatment
blockers 46 54 1170 1178 I-treatment
and 55 58 1179 1182 O
who 59 62 1183 1186 O
are 63 66 1187 1190 O
unable 67 73 1191 1197 O
to 74 76 1198 1200 O
stop 77 81 1201 1205 O
for 82 85 1206 1209 O
the 86 89 1210 1213 O
duration 90 98 1214 1222 O
of 99 101 1223 1225 O
the 102 105 1226 1229 O
study 106 111 1230 1235 O

Patients 0 8 1236 1244 O
with 9 13 1245 1249 O
an 14 16 1250 1252 O
allergy 17 24 1253 1260 O
to 25 27 1261 1263 O
iodine 28 34 1264 1270 B-allergy_name

Patients 0 8 1271 1279 O
with 9 13 1280 1284 O
retinitis 14 23 1285 1294 B-chronic_disease
pigmentosa 24 34 1295 1305 I-chronic_disease
, 34 35 1305 1306 O
previous 36 44 1307 1315 O
diagnosis 45 54 1316 1325 O
of 55 57 1326 1328 O
nonischemic 58 69 1329 1340 B-chronic_disease
optic 70 75 1341 1346 I-chronic_disease
neuropathy 76 86 1347 1357 I-chronic_disease
, 86 87 1357 1358 O
untreated 88 97 1359 1368 O
proliferative 98 111 1369 1382 O
retinopathy 112 123 1383 1394 B-chronic_disease
or 124 126 1395 1397 O
unexplained 127 138 1398 1409 O
visual 139 145 1410 1416 B-chronic_disease
disturbance 146 157 1417 1428 I-chronic_disease

Patients 0 8 1429 1437 O
with 9 13 1438 1442 O
severe 14 20 1443 1449 O
liver 21 26 1450 1455 B-chronic_disease
disease 27 34 1456 1463 I-chronic_disease
( 35 36 1464 1465 O
AST 36 39 1465 1468 B-clinical_variable
> 40 41 1469 1470 O
3x 42 44 1471 1473 B-lower_bound
normal 45 51 1474 1480 I-lower_bound
, 51 52 1480 1481 O
alkaline 53 61 1482 1490 B-clinical_variable
phosphatase 62 73 1491 1502 I-clinical_variable
or 74 76 1503 1505 O
bilirubin 77 86 1506 1515 B-clinical_variable
> 87 88 1516 1517 O
2x 89 91 1518 1520 B-lower_bound
normal 92 98 1521 1527 I-lower_bound
) 98 99 1527 1528 O

Patients 0 8 1529 1537 O
with 9 13 1538 1542 O
sickle 14 20 1543 1549 B-chronic_disease
cell 21 25 1550 1554 I-chronic_disease
anemia 26 32 1555 1561 I-chronic_disease
, 32 33 1561 1562 O
multiple 34 42 1563 1571 B-cancer
myeloma 43 50 1572 1579 I-cancer
, 50 51 1579 1580 O
leukemia 52 60 1581 1589 B-cancer
or 61 63 1590 1592 O
penile 64 70 1593 1599 B-chronic_disease
deformities 71 82 1600 1611 I-chronic_disease
placing 83 90 1612 1619 O
them 91 95 1620 1624 O
at 96 98 1625 1627 O
risk 99 103 1628 1632 O
for 104 107 1633 1636 O
priapism 108 116 1637 1645 B-chronic_disease
( 117 118 1646 1647 O
angulation 118 128 1647 1657 O
, 128 129 1657 1658 O
cavernosal 130 140 1659 1669 B-chronic_disease
fibrosis 141 149 1670 1678 I-chronic_disease
or 150 152 1679 1681 O
Peyronie 153 161 1682 1690 B-chronic_disease
's 161 163 1690 1692 I-chronic_disease
disease 164 171 1693 1700 I-chronic_disease
) 171 172 1700 1701 O

Pericardial 0 11 1702 1713 B-chronic_disease
disease 12 19 1714 1721 I-chronic_disease

Peritoneal 0 10 1722 1732 B-treatment
or 11 13 1733 1735 O
hemodialysis 14 26 1736 1748 B-treatment
within 27 33 1749 1755 O
90 34 36 1756 1758 B-upper_bound
days 37 41 1759 1763 I-upper_bound
or 42 44 1764 1766 O
anticipation 45 57 1767 1779 O
that 58 62 1780 1784 O
dialysis 63 71 1785 1793 O
or 72 74 1794 1796 O
ultrafiltration 75 90 1797 1812 B-treatment
of 91 93 1813 1815 O
any 94 97 1816 1819 O
form 98 102 1820 1824 O
will 103 107 1825 1829 O
be 108 110 1830 1832 O
required 111 119 1833 1841 O
during 120 126 1842 1848 O
the 127 130 1849 1852 O
study 131 136 1853 1858 O
period 137 143 1859 1865 O

Prazosin 0 8 1866 1874 B-treatment

Pregnant 0 8 1875 1883 B-pregnancy

Prior 0 5 1884 1889 O
diagnosis 6 15 1890 1899 O
of 16 18 1900 1902 O
intrinsic 19 28 1903 1912 B-chronic_disease
renal 29 34 1913 1918 I-chronic_disease
diseases 35 43 1919 1927 I-chronic_disease
including 44 53 1928 1937 O
renal 54 59 1938 1943 B-clinical_variable
artery 60 66 1944 1950 I-clinical_variable
stenosis 67 75 1951 1959 I-clinical_variable
of 76 78 1960 1962 O
> 79 80 1963 1964 O
50 81 83 1965 1967 B-lower_bound
% 83 84 1967 1968 I-lower_bound

Received 0 8 1969 1977 O
an 9 11 1978 1980 O
investigational 12 27 1981 1996 B-treatment
drug 28 32 1997 2001 I-treatment
within 33 39 2002 2008 O
1 40 41 2009 2010 B-upper_bound
month 42 47 2011 2016 I-upper_bound
prior 48 53 2017 2022 I-upper_bound
to 54 56 2023 2025 O
dosing 57 63 2026 2032 O

Second 0 6 2033 2039 B-lower_bound
or 7 9 2040 2042 O
third 10 15 2043 2048 B-upper_bound
degree 16 22 2049 2055 I-upper_bound
heart 23 28 2056 2061 B-chronic_disease
block 29 34 2062 2067 I-chronic_disease
without 35 42 2068 2075 O
a 43 44 2076 2077 O
permanent 45 54 2078 2087 O
cardiac 55 62 2088 2095 B-treatment
pacemaker 63 72 2096 2105 I-treatment

Serum 0 5 2106 2111 B-clinical_variable
potassium 6 15 2112 2121 I-clinical_variable
of 16 18 2122 2124 O
< 19 20 2125 2126 O
3.2 21 24 2127 2130 B-upper_bound
mEq 25 28 2131 2134 I-upper_bound
/ 28 29 2134 2135 I-upper_bound
dL 29 31 2135 2137 I-upper_bound
or 32 34 2138 2140 O
> 35 36 2141 2142 O
5.9 37 40 2143 2146 B-lower_bound
mEq 41 44 2147 2150 I-lower_bound
/ 44 45 2150 2151 I-lower_bound
dL 45 47 2151 2153 I-lower_bound

Serum 0 5 2154 2159 B-clinical_variable
sodium 6 12 2160 2166 I-clinical_variable
of 13 15 2167 2169 O
< 16 17 2170 2171 O
125 18 21 2172 2175 B-upper_bound
mEq 22 25 2176 2179 I-upper_bound
/ 25 26 2179 2180 I-upper_bound
dL 26 28 2180 2182 I-upper_bound
or 29 31 2183 2185 O
> 32 33 2186 2187 O
150 34 37 2188 2191 B-lower_bound
mEq 38 41 2192 2195 I-lower_bound
/ 41 42 2195 2196 I-lower_bound
dL 42 44 2196 2198 I-lower_bound

Severe 0 6 2199 2205 O
congenital 7 17 2206 2216 B-chronic_disease
heart 18 23 2217 2222 I-chronic_disease
diseases 24 32 2223 2231 I-chronic_disease

Silodosin 0 9 2232 2241 B-treatment

Stroke 0 6 2242 2248 B-chronic_disease
within 7 13 2249 2255 O
3 14 15 2256 2257 B-upper_bound
months 16 22 2258 2264 I-upper_bound
of 23 25 2265 2267 O
screening 26 35 2268 2277 O
or 36 38 2278 2280 O
other 39 44 2281 2286 O
evidence 45 53 2287 2295 O
of 54 56 2296 2298 O
significantly 57 70 2299 2312 O
compromised 71 82 2313 2324 O
Central 83 90 2325 2332 O
Nervous 91 98 2333 2340 O
System 99 105 2341 2347 O
( 106 107 2348 2349 O
CNS 107 110 2349 2352 O
) 110 111 2352 2353 O
perfusion 112 121 2354 2363 O

Sustained 0 9 2364 2373 O
ventricular 10 21 2374 2385 B-chronic_disease
tachycardia 22 33 2386 2397 I-chronic_disease

Systolic 0 8 2398 2406 B-clinical_variable
blood 9 14 2407 2412 I-clinical_variable
pressure 15 23 2413 2421 I-clinical_variable
< 24 25 2422 2423 O
90 26 28 2424 2426 B-upper_bound
mmHg 29 33 2427 2431 I-upper_bound
or 34 36 2432 2434 O
> 37 38 2435 2436 O
180 39 42 2437 2440 B-lower_bound
mm 43 45 2441 2443 I-lower_bound
Hg 46 48 2444 2446 I-lower_bound

Tamsulosin 0 10 2447 2457 B-treatment

Terazosin 0 9 2458 2467 B-treatment

Valve 0 5 2468 2473 O
disease 6 13 2474 2481 O
( 14 15 2482 2483 O
> 15 16 2483 2484 O
moderate 17 25 2485 2493 O
aortic 26 32 2494 2500 O
or 33 35 2501 2503 O
mitral 36 42 2504 2510 O
stenosis 43 51 2511 2519 B-chronic_disease
; 51 52 2519 2520 O
> 53 54 2521 2522 O
moderate 55 63 2523 2531 O
aortic 64 70 2532 2538 B-chronic_disease
or 71 73 2539 2541 I-chronic_disease
mitral 74 80 2542 2548 I-chronic_disease
regurgitation 81 94 2549 2562 I-chronic_disease
) 94 95 2562 2563 O

Women 0 5 2564 2569 B-gender
of 6 8 2570 2572 O
child 9 14 2573 2578 O
bearing 15 22 2579 2586 O
potential 23 32 2587 2596 O
who 33 36 2597 2600 O
do 37 39 2601 2603 O
not 40 43 2604 2607 O
have 44 48 2608 2612 O
a 49 50 2613 2614 O
negative 51 59 2615 2623 B-pregnancy
pregnancy 60 69 2624 2633 I-pregnancy
test 70 74 2634 2638 O
at 75 77 2639 2641 O
study 78 83 2642 2647 O
entry 84 89 2648 2653 O
and 90 93 2654 2657 O
who 94 97 2658 2661 O
are 98 101 2662 2665 O
not 102 105 2666 2669 O
using 106 111 2670 2675 B-contraception_consent
effective 112 121 2676 2685 I-contraception_consent
contraception 122 135 2686 2699 I-contraception_consent

a 0 1 2700 2701 O
minimal 2 9 2702 2709 O
distance 10 18 2710 2718 O
on 19 21 2719 2721 O
6 22 23 2722 2723 O
- 23 24 2723 2724 O
minute 24 30 2724 2730 O
walk 31 35 2731 2735 O
of 36 38 2736 2738 O
equal 39 44 2739 2744 O
or 45 47 2745 2747 O
> 48 49 2748 2749 O
450 49 52 2749 2752 B-lower_bound
meters 53 59 2753 2759 I-lower_bound
will 60 64 2760 2764 O
be 65 67 2765 2767 O
recruited 68 77 2768 2777 O
and 78 81 2778 2781 O
calculated 82 92 2782 2792 O
creatinine 93 103 2793 2803 B-clinical_variable
clearance 104 113 2804 2813 I-clinical_variable
of 114 116 2814 2816 O
equal 117 122 2817 2822 O
or 123 125 2823 2825 O
less 126 130 2826 2830 O
than 131 135 2831 2835 O
90 136 138 2836 2838 B-upper_bound
ml 139 141 2839 2841 I-upper_bound
/ 141 142 2841 2842 I-upper_bound
min 142 145 2842 2845 I-upper_bound
and 146 149 2846 2849 O
greater 150 157 2850 2857 O
than 158 162 2858 2862 O
30 163 165 2863 2865 B-lower_bound
ml 166 168 2866 2868 I-lower_bound
/ 168 169 2868 2869 I-lower_bound
min 169 172 2869 2872 I-lower_bound
, 172 173 2872 2873 O
using 174 179 2874 2879 O
the 180 183 2880 2883 O
( 184 185 2884 2885 O
MDRD 185 189 2885 2889 O
- 189 190 2889 2890 O
measurement 190 201 2890 2901 O
of 202 204 2902 2904 O
renal 205 210 2905 2910 B-chronic_disease
dysfunction 211 222 2911 2922 I-chronic_disease
, 222 223 2922 2923 O
formula 224 231 2924 2931 O
) 231 232 2931 2932 O
assessed 233 241 2933 2941 O
within 242 248 2942 2948 O
the 249 252 2949 2952 O
past 253 257 2953 2957 B-upper_bound
36 258 260 2958 2960 I-upper_bound
months 261 267 2961 2967 I-upper_bound

have 0 4 2968 2972 O
undergone 5 14 2973 2982 O
percutaneous 15 27 2983 2995 B-treatment
transluminal 28 40 2996 3008 I-treatment
coronary 41 49 3009 3017 I-treatment
angiography 50 61 3018 3029 I-treatment
( 62 63 3030 3031 I-treatment
PTCA 63 67 3031 3035 I-treatment
) 67 68 3035 3036 I-treatment
or 69 71 3037 3039 O
coronary 72 80 3040 3048 B-treatment
artery 81 87 3049 3055 I-treatment
bypass 88 94 3056 3062 I-treatment
grafting 95 103 3063 3071 I-treatment
( 104 105 3072 3073 I-treatment
CABG 105 109 3073 3077 I-treatment
) 109 110 3077 3078 I-treatment
within 111 117 3079 3085 O
60 118 120 3086 3088 B-upper_bound
days 121 125 3089 3093 I-upper_bound
prior 126 131 3094 3099 I-upper_bound
to 132 134 3100 3102 O
consent 135 142 3103 3110 O

no 0 2 3111 3113 O
clinical 3 11 3114 3122 O
signs 12 17 3123 3128 O
or 18 20 3129 3131 O
symptoms 21 29 3132 3140 O
of 30 32 3141 3143 O
congestive 33 43 3144 3154 B-chronic_disease
heart 44 49 3155 3160 I-chronic_disease
failure 50 57 3161 3168 I-chronic_disease

nursing 0 7 3169 3176 O
women 8 13 3177 3182 B-gender

requires 0 8 3183 3191 O
either 9 15 3192 3198 O
PTCA 16 20 3199 3203 B-treatment
or 21 23 3204 3206 O
CABG 24 28 3207 3211 B-treatment
at 29 31 3212 3214 O
the 32 35 3215 3218 O
time 36 40 3219 3223 O
of 41 43 3224 3226 O
consent 44 51 3227 3234 O

ventricular 0 11 3235 3246 B-chronic_disease
fibrillation 12 24 3247 3259 I-chronic_disease
within 25 31 3260 3266 O
14 32 34 3267 3269 B-upper_bound
days 35 39 3270 3274 I-upper_bound
of 40 42 3275 3277 O
screening 43 52 3278 3287 O

